These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17151708)

  • 1. Bisphosphonates, osteonecrosis of the jaw, and pharmacovigilance.
    Doogue M
    N Z Med J; 2006 Dec; 119(1246):U2334. PubMed ID: 17151708
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteonecrosis of the jaw due to bisphosphonates.
    Prescrire Int; 2008 Oct; 17(97):202-3. PubMed ID: 19536938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations.
    Radfar L; Masood F
    J Okla Dent Assoc; 2008; 99(7):28-9. PubMed ID: 18595621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on osteonecrosis of the jaws and bisphosphonates.
    Chehade MJ
    Climacteric; 2007 Oct; 10(5):440-1. PubMed ID: 17852148
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral bisphosphonates and osteonecrosis of the jaw.
    Wynn RL
    Gen Dent; 2007; 55(1):8-10. PubMed ID: 17333956
    [No Abstract]   [Full Text] [Related]  

  • 6. Aromatase inhibitors associated osteonecrosis of jaw: signal refining to identify pseudo safety signals.
    Neha R; Beulah E; Anusha B; Vasista S; Stephy C; Subeesh V
    Int J Clin Pharm; 2020 Apr; 42(2):721-727. PubMed ID: 32270377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates and osteonecrosis of the jaw.
    Shenker NG; Jawad AS
    Rheumatology (Oxford); 2007 Jul; 46(7):1049-51. PubMed ID: 17500074
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent reports link bisphosphonates use to osteonecrosis.
    Marunick M; Miller R; Gordon S
    Todays FDA; 2006 Mar; 18(3):26-31. PubMed ID: 16639805
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduced serum levels of Interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration.
    Oteri G; Allegra A; Bellomo G; Alonci A; Nastro E; Penna G; Catalfamo L; Cicciù D; De Ponte FS; Musolino C
    Cytokine; 2008 Aug; 43(2):103-4. PubMed ID: 18585926
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases].
    Gering A; Grange L; Villier C; Woeller A; Mallaret M
    Therapie; 2007; 62(1):49-54. PubMed ID: 17374348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates.
    Bagán J; Blade J; Cozar JM; Constela M; García Sanz R; Gómez Veiga F; Lahuerta JJ; Lluch A; Massuti B; Morote J; San Miguel JF; Solsona E
    Med Oral Patol Oral Cir Bucal; 2007 Aug; 12(4):E336-40. PubMed ID: 17664922
    [No Abstract]   [Full Text] [Related]  

  • 12. Avascular necrosis of bone in leukemia and osteonecrosis of jaw by bisphosphonates.
    Nastro E; Allegra A; Oteri G; Ferlito S; Alonci A; Bellomo G; D'Angelo A; Tolomeo A; Cicciù D; De Ponte FS; Musolino C
    J Oral Maxillofac Surg; 2009 Dec; 67(12):2701-3. PubMed ID: 19926001
    [No Abstract]   [Full Text] [Related]  

  • 13. Osteonecrosis of the jaw and bisphosphonates.
    Khan A
    BMJ; 2010 Feb; 340():c246. PubMed ID: 20124367
    [No Abstract]   [Full Text] [Related]  

  • 14. Osteonecrosis of the jaw related to the use of bisphosphonates.
    Van den Wyngaert T; Huizing MT; Vermorken JB
    Curr Opin Oncol; 2007 Jul; 19(4):315-22. PubMed ID: 17545793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates and osteonecrosis of the jaws.
    Mariotti A
    J Dent Educ; 2008 Aug; 72(8):919-29. PubMed ID: 18676801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The buzz about bisphosphonates.
    Farrar SK
    LDA J; 2005; 64(3):27. PubMed ID: 16639795
    [No Abstract]   [Full Text] [Related]  

  • 17. Osteonecrosis of the jaw and bisphosphonates--putting the risk in perspective.
    Bolland M; Hay D; Grey A; Reid I; Cundy T
    N Z Med J; 2006 Dec; 119(1246):U2339. PubMed ID: 17151713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates.
    Kraj M; Pogłód R; Maj S; Owczarska K
    Acta Pol Pharm; 2006; 63(5):450-2. PubMed ID: 17357613
    [No Abstract]   [Full Text] [Related]  

  • 19. Bisphosphonates and osteonecrosis of the jaws: science and rationale.
    Gutta R; Louis PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):186-93. PubMed ID: 17448709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonecrosis of the jaw: balancing the benefits and risks of oral bisphosphonate treatment for osteoporosis.
    Jeffcoat M; Watts NB
    Gen Dent; 2008; 56(1):96-102; quiz 103-4, 111-2. PubMed ID: 18254568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.